CDH2 and renal carcinoma: Many biomolecules, including epithelial-mesenchymal transition (EMT) markers such as N-cadherin[22] and vimentin[19] and human leucocyte molecules such as HLA-G and HLA-E[23], are reported to be biomarkers for renal cancer.